Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib for Eliminating Circulating Tumour Cells in Metastatic Breast Cancer
NCT00694252Phase 2Completed
- Sponsor
- University Hospital of Crete
- Start
- Jul 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by University Hospital of Crete. Started Jul 2008; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00694252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00694252.